Corient Private Wealth LLC Purchases Shares of 10,100 Enhabit, Inc. (NYSE:EHAB)

Corient Private Wealth LLC purchased a new stake in Enhabit, Inc. (NYSE:EHABFree Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 10,100 shares of the company’s stock, valued at approximately $79,000.

Several other institutional investors and hedge funds also recently modified their holdings of EHAB. FMR LLC raised its position in Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares in the last quarter. Intech Investment Management LLC bought a new stake in shares of Enhabit in the 3rd quarter valued at about $96,000. Stoneridge Investment Partners LLC raised its holdings in shares of Enhabit by 22.6% in the 4th quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company’s stock valued at $98,000 after purchasing an additional 2,308 shares during the period. Zacks Investment Management acquired a new stake in Enhabit in the 3rd quarter valued at about $107,000. Finally, Point72 DIFC Ltd bought a new position in Enhabit during the third quarter worth about $108,000.

Enhabit Price Performance

Shares of EHAB opened at $8.85 on Thursday. The company’s 50-day moving average is $8.57 and its 200-day moving average is $8.00. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The firm has a market capitalization of $446.75 million, a PE ratio of -3.81 and a beta of 1.80. Enhabit, Inc. has a fifty-two week low of $6.85 and a fifty-two week high of $11.35.

Analyst Ratings Changes

Separately, Jefferies Financial Group restated a “buy” rating on shares of Enhabit in a research note on Thursday, March 6th.

Check Out Our Latest Analysis on EHAB

About Enhabit

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Featured Stories

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHABFree Report).

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.